Eiger BioPharmaceuticals, Inc.
EIGRQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$74,963 | -$96,776 | -$33,917 | -$65,051 |
| Dep. & Amort. | $750 | $842 | $799 | $645 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,008 | $8,317 | $7,901 | $5,973 |
| Change in WC | -$5,733 | $481 | -$1,341 | -$5,897 |
| Other Non-Cash | $12,023 | $13,514 | -$33,694 | $10,307 |
| Operating Cash Flow | -$74,548 | -$83,010 | -$71,517 | -$63,185 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$234 | -$340 | -$48,732 | -$258 |
| Net Acquisitions | $0 | $0 | $281 | $0 |
| Inv. Purchases | -$19,388 | -$75,101 | -$84,647 | -$128,295 |
| Inv. Sales/Matur. | $93,850 | $85,073 | $99,630 | $83,766 |
| Other Inv. Act. | $74,462 | $9,972 | $95,000 | -$44,529 |
| Investing Cash Flow | $74,228 | $9,632 | $61,532 | -$44,787 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $6,564 | $0 | $0 |
| Stock Issued | $41 | $71,402 | $3,040 | $96,779 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $41 | -$1,011 | $127 | $684 |
| Financing Cash Flow | $41 | $76,955 | $3,342 | $97,463 |
| Forex Effect | -$79 | $0 | $0 | $0 |
| Net Chg. in Cash | -$358 | $3,577 | -$6,643 | -$10,509 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,798 | $22,221 | $28,864 | $39,373 |
| End Cash | $25,440 | $25,798 | $22,221 | $28,864 |
| Free Cash Flow | -$74,782 | -$83,350 | -$120,249 | -$63,443 |